Motoko Sasaki (Sasaki Motoko, M Sasaki)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Long Noncoding Rna

Top Venues

Virchows Archiv : an international journal of pathology

Journal of hepato-biliary-pancreatic sciences

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Virchows Archiv : an international journal of pathology (2024)
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Virchows Archiv : an international journal of pathology 484 (6) (2024)
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Virchows Archiv : an international journal of pathology 484 (6) (2024)
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Virchows Archiv : an international journal of pathology 484 (6) (2024)
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study. Virchows Archiv : an international journal of pathology 484 (6) (2024)
Soo Ryang Kim, Soo Ki Kim, Yu-Ichiro Koma, Motoko Sasaki, Akira Asai, Hiroki Nishikawa
Hepatic Inflammatory Pseudotumor-Focusing on Its Heterogeneity. Diagnostics (Basel, Switzerland) 13 (17) (2023)
Motoko Sasaki, Sato Yasunori, Nakanuma Yasuni
Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components. Histopathology (2023)
Motoko Sasaki, Y Sato, Y Nakanuma
Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma? Histopathology 80 (5) (2022)
Motoko Sasaki, Yasunori Sato
An immunohistochemical panel of insulin-like growth factor II mRNA-binding protein 3 (IMP3), enhancer of zeste homolog 2 (EZH2), and p53 is useful for a diagnosis in bile duct biopsy. Virchows Archiv : an international journal of pathology 479 (4) (2021)
Yasunori Sato, Shogo Tanaka, Masahiko Kinoshita, Shigekazu Takemura, Hiroji Shinkawa, Takashi Kokudo, Kiyoshi Hasegawa, Hiromu Tanaka, Hidero Yoshimoto, Akira Mori, Minako Yamamura, Motoko Sasaki, Kenichi Harada, Shoji Kubo
Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy. Journal of hepato-biliary-pancreatic sciences 27 (11) (2020)
Motoko Sasaki, Yasunori Sato, Yasuni Nakanuma
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma. Histopathology 78 (2) (2020)
Motoko Sasaki, Fang-Ying Kuo, Chao-Cheng Huang, Paul E Swanson, Chao-Long Chen, Jiin-Haur Chuang, Matthew M Yeh
Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study. Histopathology 72 (7) (2018)